No evidence for overexpression of the p53 protein and mutations in exons 4-9 of the p53 gene in a large family with adenomatous polyposis

American Journal of Gastroenterology

Volumn 93, Issue 9, 1998, Pages 1524-1526

  Aktas, Dilek ^a   Ayhan, A ^a   Tuncbilek E ^a   Ozdemir A ^a   Uzunalimoglu B ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; COLON CANCER; DISEASE ASSOCIATION; FAMILIAL POLYPOSIS; FEMALE; GENETIC LINKAGE; GENETIC SCREENING; HUMAN; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT;

ADENOMATOUS POLYPOSIS COLI; ADULT; EXONS; FEMALE; GENES, P53; HUMANS; MALE; MUTATION; PEDIGREE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032172849     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)00295-0     Document Type: Article

References (17)

1. 1. Stern HS. Contributions of molecular genetics to the clinical managements of colorectal cancer. Am J Surg 1996;171:10-15.
2. 2. Powell SM, Peterson GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Eng J Med 1993;329:1982-7.
3. 3. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Eng J Med 1996;334:82-7.
4. 4. Maniatis T, Fritsch E, Sambrook J. Molecular cloning: A laboratory manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1982.
5. 5. Ayhan A, Yasui W, Yokozaki H, et al. Genetic abnormalities and expression of p53 in human colon carcinomas. Int J Oncol 1992;1: 431-7.
6. 6. Mashiyama S, Murakami Y, Yoshimoto T, et al. Detection of p53 gene mutations in human brain tumours by single-strand conformation polymorphism, analysis of polymerase chain reaction products. Oncogene 1991;6:1313-8.
7. 7. Ainsworth PJ, Surh LC, Mackie MB: Diagnosis single strand conformation polymorphism, (SSCP): A simple non-radioisotopic methos as applied to a Tay-Sachs B1 variant. Nuc Acid Res 1991;19:405.
8. 8. Achille A, Scupoli MT, Magalini AR, et al. APC gene mutations and allelic losses in sporadic ampullary tumors: Evidence of genetic difference from tumors associated with familial adenomatous polyposis. Int J Cancer 1996;68:305-12.
9. 9. Bala S, Wünsch PH, Ballhausen WG. Childhood hepatocelluler adenoma in familial adenomatous polyposis: Mutations in adenomatous polyposis coli gene and p53. Gastroenterology 1997;112:919-22.
10. 10. Rodrigues NR, Rowan A, Smith MEF, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-9.
11. 11. Levi E, Stryker SJ, Rao MS. p53 Protein overexpression in colorectal tumours from patients with familial adenomatous polyposis: Is it an early or late event? Am J Gastroen 1996;91:11-14.
12. 12. Ichii S, Takeda S, Horii A, et al. Detailed analysis of genetic alterations in colorectal tumours from patients with and without familial adenomatous polyposis (FAP). Oncogene 1993;8:2399-2405.
13. 13. Shirasawa S, Urabe K, Yanagawa Y, et al. p53 Gene mutations in colorectal tumours from patients with familial polyposis coli. Cancer Res 1991;51:2874-8.
14. 14. Kikuchi-Yanoshita R, Konishi M, Ito S, et al. Genetic changes of both alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenamatous polyposis patients. Cancer Res 1992;52:3965-71.
15. 15. Evans DGR, Guy SP, Thakker N, et al. Non-penetrance and late appearance of polyposis in families with familial adenomatous polyposis. Gut 1993;34:1389-93.
16. 16. Jagelman DG. Clinical management of familial adenomatous polyposis. Cancer Surv 1989;8:159-67.
17. 17. Burn J, Chapman P, Delhanty J, et al. The Northern region genetic register for familial adenomatous polyposis coli: Use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculation. J Med Genet 1991;28:289-96.